322 related articles for article (PubMed ID: 36657446)
1. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.
Wang HM; Zhang CY; Peng KC; Chen ZX; Su JW; Li YF; Li WF; Gao QY; Zhang SL; Chen YQ; Zhou Q; Xu C; Xu CR; Wang Z; Su J; Yan HH; Zhang XC; Chen HJ; Wu YL; Yang JJ
Cell Rep Med; 2023 Feb; 4(2):100911. PubMed ID: 36657446
[TBL] [Abstract][Full Text] [Related]
2. Scientific Validation and Clinical Application of Lung Cancer Organoids.
Lee D; Kim Y; Chung C
Cells; 2021 Nov; 10(11):. PubMed ID: 34831235
[TBL] [Abstract][Full Text] [Related]
3. [Application and Research Progress of Lung Cancer Organoid in Precision Medicine
for Lung Cancer].
Huang Z; Li B; Wang Y; Xue J; Wei Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):276-282. PubMed ID: 38769830
[TBL] [Abstract][Full Text] [Related]
4. Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids.
Park D; Lee D; Kim Y; Park Y; Lee YJ; Lee JE; Yeo MK; Kang MW; Chong Y; Han SJ; Choi J; Park JE; Koh Y; Lee J; Park Y; Kim R; Lee JS; Choi J; Lee SH; Ku B; Kang DH; Chung C
Cells; 2023 Jul; 12(14):. PubMed ID: 37508518
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL
Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909
[TBL] [Abstract][Full Text] [Related]
7. Applications of lung cancer organoids in precision medicine: from bench to bedside.
Li H; Chen Z; Chen N; Fan Y; Xu Y; Xu X
Cell Commun Signal; 2023 Dec; 21(1):350. PubMed ID: 38057851
[TBL] [Abstract][Full Text] [Related]
8. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
9. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A
Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795
[TBL] [Abstract][Full Text] [Related]
10. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.
Shu D; Shen M; Li K; Han X; Li H; Tan Z; Wang Y; Peng Y; Tang Z; Qu C; Jin A; Liu S
Ann Med; 2022 Dec; 54(1):2581-2597. PubMed ID: 36194178
[TBL] [Abstract][Full Text] [Related]
11. [Application of Organoids in Lung Cancer Precision Medicine].
Jia Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):615-620. PubMed ID: 32702796
[TBL] [Abstract][Full Text] [Related]
12. Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.
Dijkstra KK; Monkhorst K; Schipper LJ; Hartemink KJ; Smit EF; Kaing S; de Groot R; Wolkers MC; Clevers H; Cuppen E; Voest EE
Cell Rep; 2020 May; 31(5):107588. PubMed ID: 32375033
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week.
Hu Y; Sui X; Song F; Li Y; Li K; Chen Z; Yang F; Chen X; Zhang Y; Wang X; Liu Q; Li C; Zou B; Chen X; Wang J; Liu P
Nat Commun; 2021 May; 12(1):2581. PubMed ID: 33972544
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response.
Ramamoorthy P; Thomas SM; Kaushik G; Subramaniam D; Chastain KM; Dhar A; Tawfik O; Kasi A; Sun W; Ramalingam S; Gunewardena S; Umar S; Mammen JM; Padhye SB; Weir SJ; Jensen RA; Sittampalam GS; Anant S
Cancer Res; 2019 Apr; 79(7):1681-1695. PubMed ID: 30674533
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
Ren X; Chen W; Yang Q; Li X; Xu L
J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
[TBL] [Abstract][Full Text] [Related]
16. Moving toward precision medicine with lung cancer organoids.
Kim J; Minna JD
Cell Rep Med; 2023 Feb; 4(2):100952. PubMed ID: 36812886
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer organoids, a promising model still with long way to go.
Ma HC; Zhu YJ; Zhou R; Yu YY; Xiao ZZ; Zhang HB
Crit Rev Oncol Hematol; 2022 Mar; 171():103610. PubMed ID: 35114386
[TBL] [Abstract][Full Text] [Related]
18. Promising preclinical models for lung cancer research-lung cancer organoids: a narrative review.
Chen X; Ye L; Wang H; Liu X; Zhao L; Xu K; Liu Y; He Y
Transl Lung Cancer Res; 2024 Mar; 13(3):623-634. PubMed ID: 38601435
[TBL] [Abstract][Full Text] [Related]
19. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine.
Seol HS; Oh JH; Choi E; Kim S; Kim H; Nam EJ
J Gynecol Oncol; 2023 May; 34(3):e35. PubMed ID: 36659831
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening.
Kim M; Mun H; Sung CO; Cho EJ; Jeon HJ; Chun SM; Jung DJ; Shin TH; Jeong GS; Kim DK; Choi EK; Jeong SY; Taylor AM; Jain S; Meyerson M; Jang SJ
Nat Commun; 2019 Sep; 10(1):3991. PubMed ID: 31488816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
